Innocan (INNO:CSE) has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
Visited 2 times, 1 visit(s) today
Last modified: July 27, 2026
